Analysis of the Value of Quantitative Features in Multimodal MRI Images to Construct a Radio-Omics Model for Breast Cancer Diagnosis

References

• Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124(1):13–26. doi:10.1038/s41416-020-01161-4
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Fumoleau P, Roché H, Kerbrat P, et al; French Adjuvant Study Group. Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French results. Ann Oncol. 2006;17(1):85–92. doi:10.1093/annonc/mdj034
   PubMed Web of Science ®Google Scholar
• Wang J, Sun T, Ouyang Q, Han Y, Xu B. A phase Ib study of TQB2450 plus anlotinib in patients with advanced triple-negative breast cancer. iScience. 2023;26(6):106876. doi:10.1016/j.isci.2023.106876
   PubMed Web of Science ®Google Scholar
• Sumkin JH, Berg WA, Carter GJ, et al. Diagnostic performance of MRI, molecular breast imaging, and contrast-enhanced mammography in women with newly diagnosed breast cancer. Radiology. 2019;293(3):531–540. doi:10.1148/radiol.2019190887
   PubMed Web of Science ®Google Scholar
• Hollingsworth AB, Pearce MR, Stough RG. Breast cancer survival following MRI detection in a high-risk screening program. Breast J. 2020;26(5):991–994. doi:10.1111/tbj.13813
   PubMed Web of Science ®Google Scholar
• Marshall H, Pham R, Sieck L, Plecha D. Implementing abbreviated MRI screening into a breast imaging practice. AJR Am J Roentgenol. 2019;213(1):234–237. doi:10.2214/AJR.18.20396
   PubMed Web of Science ®Google Scholar
• Cui Q, Sun L, Zhang Y, et al. Value of breast MRI omics features and clinical characteristics in Breast Imaging Reporting and Data System (BI-RADS) category 4 breast lesions: an analysis of radiomics-based diagnosis. Ann Transl Med. 2021;9(22):1677. doi:10.21037/atm-21-5441
   PubMed Web of Science ®Google Scholar
• Upadhaya T, Morin O, Park CC. Second-harmonic generation image based histomics for the prediction of breast cancer recurrence. Int J Radiat Oncol Biol Phys. 2020;108(3):e70–e71. doi:10.1016/j.ijrobp.2020.07.1144
   PubMed Web of Science ®Google Scholar
• Li Q, Luo Y, Liu D, Li B, Liu Y, Wang T. Construction and prognostic value of enhanced CT image omics model for noninvasive prediction of HRG in bladder cancer based on logistic regression and support vector machine algorithm. Front Oncol. 2023;12:966506. doi:10.3389/fonc.2022.966506
   PubMed Web of Science ®Google Scholar
• LoGullo R, Horvat J, Reiner J, Pinker K. Multimodale, parametrische und genetische brustbildgebung [Multimodal, multiparametric and genetic breast imaging]. Radiologe. 2021;61(2):183–191. doi:10.1007/s00117-020-00801-3
   PubMedGoogle Scholar
• Zaric O, Farr A, Poblador Rodriguez E, et al. 7T CEST MRI: a potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancer. Magn Reson Imaging. 2019;59:77–87. doi:10.1016/j.mri.2019.03.004
   PubMed Web of Science ®Google Scholar
• Wang X, Wang X, Zhang Y, et al. Development of the prediction model based on clinical-imaging omics: molecular typing and sentinel lymph node metastasis of breast cancer. Ann Transl Med. 2022;10(13):749. doi:10.21037/atm-22-2844
   PubMed Web of Science ®Google Scholar
• Heacock L, Lewin AA, Toth HK, Moy L, Reig B. Abbreviated MR imaging for breast cancer. Radiol Clin North Am. 2021;59(1):99–111. pii: S0033-8389(20)30115-9. doi:10.1016/j.rcl.2020.09.001
   PubMed Web of Science ®Google Scholar
• Grubstein A, Rapson Y, Stemmer SM, et al. Timing to imaging and surgery after neoadjuvant therapy for breast cancer. Clin Imaging. 2021;71:24–28. doi:10.1016/j.clinimag.2020.10.043
   PubMed Web of Science ®Google Scholar
• Carmona-Bozo JC, Manavaki R, Woitek R, et al. Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging. Eur Radiol. 2021;31(1):333–344. doi:10.1007/s00330-020-07067-2
   PubMed Web of Science ®Google Scholar
• Pujara AC, Kim E, Axelrod D, Melsaether AN. PET/MRI in Breast Cancer. J Magn Reson Imaging. 2019;49(2):328–342. doi:10.1002/jmri.26298
   PubMed Web of Science ®Google Scholar
• Partovi S, Sin D, Lu Z, et al. Fast MRI breast cancer screening - Ready for prime time. Clin Imaging. 2020;60(2):160–168. doi:10.1016/j.clinimag.2019.10.013
   PubMed Web of Science ®Google Scholar
• Sorace AG, Virostko J, Wu C, et al. Abstract P1-01-02: quantitative breast MRI to predict response to neoadjuvant therapy in community imaging centers: preliminary results. Cancer Res. 2019;79(4 Supplement):P1-01-02-P1-01-02. doi:10.1158/1538-7445.SABCS18-P1-01-02
   Web of Science ®Google Scholar
• Kurihara H, Shimizu C, Miyakita Y, et al. Molecular imaging using PET for breast cancer. Breast Cancer. 2016;23(1):24–32. doi:10.1007/s12282-015-0613-z
   PubMed Web of Science ®Google Scholar
• Montemezzi S, Benetti G, Bisighin MV, et al. 3T DCE-MRI radiomics improves predictive models of complete response to neoadjuvant chemotherapy in breast cancer. Front Oncol. 2021;11:630780. doi:10.3389/fonc.2021.630780
   PubMedGoogle Scholar
• Ma M, Gan L, Jiang Y, et al. Radiomics analysis based on automatic image segmentation of DCE-MRI for predicting triple-negative and nontriple-negative breast cancer. Comput Math Methods Med. 2021;2021:2140465. doi:10.1155/2021/2140465
   PubMed Web of Science ®Google Scholar
• Qi X, Wang W, Pan S, et al. Predictive value of triple negative breast cancer based on DCE-MRI multi-phase full-volume ROI clinical radiomics model. Acta Radiol. 2024;65(2):173–184. doi:10.1177/02841851231215145
   PubMed Web of Science ®Google Scholar
• Roy S, Whitehead TD, Quirk JD, et al. Optimal co-clinical radiomics: sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging. EBioMedicine. 2020;59:102963. doi:10.1016/j.ebiom.2020.102963
   PubMed Web of Science ®Google Scholar
• Zhang Q, Peng Y, Liu W, et al. Radi omics based on multimodal MRI for the Di fferential Di agnosis of B enign and M alignant breast lesi ons. J Magn Reson Imaging. 2020;52(2):596–607. doi:10.1002/jmri.27098
   PubMed Web of Science ®Google Scholar
• Latini F, Fahlström M, Fällmar D, Marklund N, Cunningham JL, Feresiadou A. Can diffusion tensor imaging (DTI) outperform standard magnetic resonance imaging (MRI) investigations in post-COVID-19 autoimmune encephalitis? Ups J Med Sci. 2022;127. doi:10.48101/ujms.v127.8562
   PubMed Web of Science ®Google Scholar
• Li Q, Yang H, Wang P, Liu X, Lv K, Ye M. XGBoost-based and tumor-immune characterized gene signature for the prediction of metastatic status in breast cancer. J Transl Med. 2022;20(1):177. doi:10.1186/s12967-022-03369-9
   PubMed Web of Science ®Google Scholar
• Pan J, Ma B, Hou X, et al. The construction of transcriptional risk scores for breast cancer based on lightGBM and multiple omics data. Math Biosci Eng. 2022;19(12):12353–12370. doi:10.3934/mbe.2022576
   PubMed Web of Science ®Google Scholar
• Tong L, Wu H, Wang MD. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer. Methods. 2021;189:74–85. doi:10.1016/j.ymeth.2020.07.008
   PubMed Web of Science ®Google Scholar
• Sun SY, Ding Y, Li Z, et al. Multiparameter MRI Model With DCE-MRI, DWI, and Synthetic MRI Improves the Diagnostic Performance of BI-RADS 4 Lesions. Front Oncol. 2021;11:699127. doi:10.3389/fonc.2021.699127
   PubMed Web of Science ®Google Scholar
• Fusco R, Sansone M, Filice S, et al. Pattern recognition approaches for breast cancer DCE-MRI classification: a systematic review. J Med Biol Eng. 2016;36(4):449–459. doi:10.1007/s40846-016-0163-7
   PubMed Web of Science ®Google Scholar
• Zhao YF, Chen Z, Zhang Y, et al. Diagnosis of breast cancer using radiomics models built based on dynamic contrast enhanced MRI combined with mammography. Front Oncol. 2021;11:774248. doi:10.3389/fonc.2021.774248
   PubMed Web of Science ®Google Scholar